Literature DB >> 14618017

Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring.

Elizabeth Stephens1, Matthew Riddle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618017     DOI: 10.1023/a:1027345927676

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  44 in total

1.  Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.

Authors:  B W Bode; T M Gross; K R Thornton; J J Mastrototaro
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

2.  A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.

Authors:  Fred Whitehouse; Davida F Kruger; Mark Fineman; Larry Shen; James A Ruggles; David G Maggs; Christian Weyer; Orville G Kolterman
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

3.  Tests of glycemia in diabetes.

Authors:  David E Goldstein; Randie R Little; Rodney A Lorenz; John I Malone; David M Nathan; Charles M Peterson
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

4.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes.

Authors:  H P Chase; L M Kim; S L Owen; T A MacKenzie; G J Klingensmith; R Murtfeldt; S K Garg
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

5.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

6.  Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Authors:  J Rosenstock; S L Schwartz; C M Clark; G D Park; D W Donley; M B Edwards
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

7.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

8.  Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.

Authors:  Carmine G Fanelli; Simone Pampanelli; Francesca Porcellati; Paolo Rossetti; Paolo Brunetti; Geremia B Bolli
Journal:  Ann Intern Med       Date:  2002-04-02       Impact factor: 25.391

9.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

10.  Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes.

Authors:  Kilty McGowan; William Thomas; Antoinette Moran
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

View more
  1 in total

1.  In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le Compte; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.